USPTO serial 79190556
OPEN UP THE FUTURE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 14, 2017
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with OPEN UP THE FUTURE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Mitsubishi Tanabe Pharma Corporation
JP
Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma Corporation
JP
Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma Corporation
JP
Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jeffrey L. Costellia
Jeffrey L. Costellia Nixon Peabody LLP799 Ninth Street NWSuite 500Washington, DC 20001Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for protection against free radicals; pharmaceutical preparations for removing free radicals from the human bodies; pharmaceutical preparations for the treatment of amyotrophic lateral sclerosis (ALS); neuroprotective medicines; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antiallergic medicines; antihypertensives; hypoglycemic agents; antidiabetic preparations; pharmaceutical preparations for the prevention of diabetic nephropathy; pharmaceutical preparations, namely, antiphlogistic agents; vaccine; pharmaceutical preparations for the treatment of autoimmune disease; pharmaceutical preparations for the treatment of cerebral infarction; pharmaceutical preparations for the treatment of multiple sclerosis; pharmaceutical preparations for the treatment of erectile dysfunction | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
- Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
- Other trademarks owned by Mitsubishi Tanabe Pharma Corporation
- Other trademarks in Class 005
- Similar marks named OPEN UP THE FUTURE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 12, 2026 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Nov 12, 2026 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Jul 20, 2024 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 27, 2024 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 27, 2024 | INPC | INVALIDATION PROCESSED | — |
| Jun 14, 2024 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 29, 2023 | C71T | CANCELLED SECTION 71 | — |
| Mar 14, 2022 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 8, 2018 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 14, 2017 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jun 22, 2017 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jun 22, 2017 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jun 14, 2017 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 7, 2017 | LIMN | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Mar 31, 2017 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Mar 14, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 27, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 27, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 7, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 15, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 2, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 2, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 2, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 2, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 31, 2016 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 31, 2016 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Sep 16, 2016 | RFNP | REFUSAL PROCESSED BY IB | — |
| Sep 2, 2016 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 31, 2016 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 31, 2016 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 31, 2016 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 30, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 29, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 29, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 26, 2016 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Aug 25, 2016 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |